Dr Adri Voogd (A.C.)

Ding, N., Geurts, S. M. E., Vriens, I. J. H., Visserman, R., van Nijnatten, T. J. A., Smidt, M., Voogd, A. C., Verloop, J., & Tjan-Heijnen, V. C. G. (2026). Real-world implementation of pertuzumab from 2013 to 2023 for de Novo HER2-positive metastatic breast cancer in the Netherlands: a population-based study. Breast, 89, Article 104888. https://doi.org/10.1016/j.breast.2026.104888

Wurfbain, L. F., Tiels, L. M., van der Sangen, M. J. C., Walstra, C. J. E. F., van Maaren, M. C., Vriens, B. E. P. J., van Oordt, C. W. M. D. H., Bloemen, J. G., Voogd, A. C., Nieuwenhuijzen, G. A. P., van den Bongard, D. H. J. G., Schipper, R.-J., & Dutch Snapshot Res Grp (2026). ASO Visual Abstract: Patterns of Care and Follow-up Evaluation of Patients with an Ipsilateral Breast Tumor Event After Breast-Conserving Surgery. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-026-20238-7

Mauritz, A. J. W., de Munck, L., Simons, J. M., Verloop, J., van Dalen, T., Elkhuizen, P. H. M., Scholten, A., Houben, R. M. A., van Leeuwen-Stok, A. E., Linn, S. C., Pijnappel, R. M., Poortmans, P. M. P., Strobbe, L. J. A., Wesseling, J., Voogd, A. C., & Boersma, L. J. (2026). Tailoring radiotherapy in cT1–2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study. The Lancet Oncology, 27(7), 808-816. https://doi.org/10.1016/S1470-2045(26)00216-0

Lenaerts, M., van der Voort, L., Smidt, M. L., van de Weijer, T., Mottaghy, F. M., Voogd, A. C., Geurts, S. M. E., Tjan-Heijnen, V. C. G., Gallagher, F. A., Aloj, L., & van Nijnatten, T. J. A. (2026). The proportion, clinical predictors, and prognostic impact of hypometabolic estrogen receptor-positive primary breast cancer on baseline [<SUP>18</SUP>F] fluorodeoxyglucose PET. Nuclear Medicine Communications, 47(6), 704-714. https://doi.org/10.1097/MNM.0000000000002133

Verheul, E. M., Doornkamp, F., Petrov, I., Siesling, S., Lingsma, H. F., Koppert, L. B., Vreven, L. W. A., Voogd, A. C., Karsten, M. M., Doppelbauer, L., Gebert, P., Kiani, N., Borstnar, S., Pharoah, P. D. P., Hedayati, E., Steyerberg, E. W., van Klaveren, D., & 4D PICTURE Consortium (2026). External validation of PREDICT Breast v3.1 for overall survival in international cohorts, including young and invasive lobular subgroups. Breast Cancer Research and Treatment, 217(2), Article 14. https://doi.org/10.1007/s10549-026-07958-w

van Tuijl, L. A., Pan, K.-Y., Basten, M., Vermeulen, R., Portengen, L., de Graeff, A., Dekker, J., Geerlings, M. I., Hoogendoorn, A. W., Lamers, F., Voogd, A. C., Abell, J., Awadalla, P., Beekman, A. T. F., Bjerkeset, O., Boyd, A., Cui, Y., Frank, P., Galenkamp, H., ... Ranchor, A. V. (2026). Psychosocial factors and the risk of cancer: An individual-participant data meta-analysis. Cancer, 132(7), Article e70271. https://doi.org/10.1002/cncr.70271

Wang, Y., Drubay, D., Jonas, S. F., Dixon-Douglas, J., Acs, B., Adams, S., André, F., Badve, S., Bataillon, G., Carter, J. M., Chia, S., Cockenpot, V., Colleoni, M. A., Criscitiello, C., Curigliano, G., Dackus, G. M. H. E., Demaria, S., Denkert, C., van Deurzen, C. H. M., ... International Immuno-Oncology Biomarker Working Group (2026). Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival. Annals of Oncology, 37(8), 1093-1105. https://doi.org/10.1016/j.annonc.2026.04.011

Tiels, L. M., Walstra, C. J. E. F., Voogd, A. C., van der Sangen, M. J. C., van Haren, E. L. W. G., Smidt, M. L., Nieuwenhuijzen, G. A. P., Schipper, R.-J., & Dutch Snapshot Res Grp (2026). Postoperative complications after salvage mastectomy and repeat breast-conserving surgery in patients with IBTR after previous breast-conserving surgery: a multicenter, retrospective cohort study. Breast Cancer Research and Treatment, 215(3), Article 71. https://doi.org/10.1007/s10549-026-07908-6

Vreven, L. W. A., Verheul, E. M., van Maaren, M. C., Doornkamp, F., Schipper, R. J., Siesling, S., Pharoah, P. D. P., Tjan-Heijnen, V. C. G., & Voogd, A. C. (2026). Comparative validation of PREDICT versions 3.1 and 2.2 for overall survival in the Dutch breast cancer population. Breast, 85, Article 104681. https://doi.org/10.1016/j.breast.2025.104681

Duijm, L. E. M., Van Der Veer, E. L., Van Beek, H. C., Setz-Pels, W., Smallenburg, V. V. B., Van Bommel, R. M. G., Coul-Froger, C. L. O. D., Gielens, M., Van Uden, D. J. P., & Voogd, A. C. (2026). Frequency and survival of delayed breast cancer diagnosis in women participating at screening mammography in the Netherlands: a population-based study. The Lancet Regional Health – Europe, 61, Article 101526. https://doi.org/10.1016/j.lanepe.2025.101526